NVCT- Nuvectis Pharma, Inc.

Name: Nuvectis Pharma, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Nuvectis Pharma, Inc. (NVCT) has 7 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. NVCT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Bentsur Ron	3.68M	$72.82M	-
10%	Mosseri Marlio Charles	3.14M	$62.14M	-
Other	Poradosu Enrique	1.81M	$35.78M	-
Other	Shemesh Shay	1.79M	$35.52M	-
VP	Carson Michael J.	200.1K	$3.96M	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 19, 2023	Bentsur Ron64	Chairman &CEO	Buy	200	$14.33	$2,866.00	-	-34.2%	-55.0%
Jul 19, 2023	Mosseri Marlio Charles46	10% Owner	Buy	8,000	$14.84	$118,720.00	+0.3%	-34.2%	-55.0%
Jul 18, 2023	Mosseri Marlio Charles46	10% Owner	Buy	9,149	$14.84	$135,771.16	+0.4%	-27.1%	-54.0%
Jul 14, 2023	Bentsur Ron64	Chairman &CEO	Buy	260	$15.52	$4,035.40	-	-36.1%	-56.0%
Jul 12, 2023	Mosseri Marlio Charles46	10% Owner	Buy	3,285	$15.09	$49,570.65	+0.1%	-28.7%	-57.5%
Jul 11, 2023	Mosseri Marlio Charles46	10% Owner	Buy	10,000	$15.36	$153,600.00	+0.4%	-29.0%	-59.3%
Jul 7, 2023	Mosseri Marlio Charles46	10% Owner	Buy	8,948	$15.19	$135,920.12	+0.4%	-28.7%	-59.4%
Jul 6, 2023	Mosseri Marlio Charles46	10% Owner	Buy	3,179	$15.01	$47,716.79	+0.1%	-27.5%	-59.3%
Jul 6, 2023	Bentsur Ron64	Chairman &CEO	Buy	320	$14.88	$4,761.60	-	-27.5%	-59.3%
Jul 5, 2023	Mosseri Marlio Charles46	10% Owner	Buy	1,176	$15.52	$18,251.52	-	-29.5%	-60.9%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC